Simplify Asset Management Inc. Has $1.45 Million Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Simplify Asset Management Inc. grew its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 78.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 15,793 shares of the medical device company's stock after buying an additional 6,925 shares during the quarter. Simplify Asset Management Inc.'s holdings in Cooper Companies were worth $1,452,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the business. State Street Corp raised its stake in shares of Cooper Companies by 1.2% in the third quarter. State Street Corp now owns 8,590,689 shares of the medical device company's stock worth $947,897,000 after acquiring an additional 104,521 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock valued at $543,979,000 after purchasing an additional 573,908 shares in the last quarter. Geode Capital Management LLC raised its position in Cooper Companies by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company's stock worth $527,476,000 after purchasing an additional 48,559 shares during the last quarter. Victory Capital Management Inc. boosted its position in Cooper Companies by 14.6% in the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after buying an additional 574,899 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Cooper Companies by 11.9% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company's stock valued at $200,665,000 after buying an additional 194,118 shares during the period. 24.39% of the stock is owned by institutional investors.

Remove Ads

Analyst Ratings Changes

Several equities analysts recently issued reports on COO shares. Stifel Nicolaus decreased their price target on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Citigroup reduced their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Finally, StockNews.com lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday, December 11th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, Cooper Companies currently has a consensus rating of "Moderate Buy" and an average price target of $110.25.

Cooper Companies Trading Up 1.3 %

Shares of COO stock traded up $1.12 on Thursday, hitting $84.98. The stock had a trading volume of 2,256,824 shares, compared to its average volume of 1,297,307. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a twelve month low of $77.05 and a twelve month high of $112.38. The company has a fifty day moving average price of $89.52 and a two-hundred day moving average price of $97.53. The firm has a market cap of $16.99 billion, a P/E ratio of 43.58, a PEG ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. As a group, analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.